Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Point72 Asset Management, L.P. | 2,086 5.300% |
2,086 (New Position) |
Filing History |
| 2023-02-14 4:21 pm Sale |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 2,124,200 7.500% |
-157,000 (-6.88%) |
Filing History |
| 2023-02-14 4:20 pm Purchase |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 1,150,648 7.400% |
189,778 (+19.75%) |
Filing History |
| 2023-02-14 4:20 pm Purchase |
2022-12-31 | 13G | Eos Energy Enterprises, Inc. EOSE |
Point72 Asset Management, L.P. | 5,535,030 6.700% |
2,493,265 (+81.97%) |
Filing History |
| 2023-02-14 4:19 pm Sale |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
Point72 Asset Management, L.P. | 69,450 0.100% |
-1,984,767 (-96.62%) |
Filing History |
| 2023-02-14 4:19 pm Sale |
2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
Point72 Asset Management, L.P. | 1,178,501 1.900% |
-1,828,637 (-60.81%) |
Filing History |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | Health Catalyst, Inc. HCAT |
Point72 Asset Management, L.P. | 1,920,253 3.500% |
-864,631 (-31.05%) |
Filing History |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management, L.P. | 30,441 1.300% |
-23,999 (-44.08%) |
Filing History |
| 2023-02-14 4:17 pm Unchanged |
2022-12-31 | 13G | Cepton, Inc. CPTN |
Point72 Asset Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:17 pm Sale |
2022-12-31 | 13G | uniQure N.V. QURE |
Point72 Asset Management, L.P. | 1,745,461 3.700% |
-1,866,230 (-51.67%) |
Filing History |
| 2023-02-14 4:16 pm Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Point72 Asset Management, L.P. | 167,509 0.300% |
-3,117,394 (-94.90%) |
Filing History |
| 2023-02-14 4:15 pm Sale |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Point72 Asset Management, L.P. | 30,702 0.100% |
-2,037,172 (-98.52%) |
Filing History |
| 2023-02-14 4:14 pm Sale |
2022-12-31 | 13G | Tactile Systems Technology, Inc. TCMD |
Point72 Asset Management, L.P. | 71,124 0.400% |
-1,111,666 (-93.99%) |
Filing History |
| 2023-02-14 4:14 pm Sale |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 2,438,138 4.200% |
-1,032,140 (-29.74%) |
Filing History |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Point72 Asset Management, L.P. | 56,207 0.200% |
-2,045,830 (-97.33%) |
Filing History |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
Point72 Asset Management, L.P. | 0 0.000% |
-6,312,371 (Position Closed) |
Filing History |
| 2023-02-14 4:12 pm Sale |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Point72 Asset Management, L.P. | 1,299,548 2.000% |
-1,817,932 (-58.31%) |
Filing History |
| 2023-02-14 4:12 pm Sale |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
Point72 Asset Management, L.P. | 10,673 0.100% |
-1,653,394 (-99.36%) |
Filing History |
| 2023-02-14 4:11 pm Sale |
2022-12-31 | 13G | Chimerix, Inc. CMRX |
Point72 Asset Management, L.P. | 75,926 0.100% |
-4,472,328 (-98.33%) |
Filing History |
| 2023-02-14 4:11 pm Sale |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 368,006 0.700% |
-2,052,303 (-84.80%) |
Filing History |